SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock
15.24 EUR
-0.1 (-0.65%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 898.602M 9.44% | 957.091M 6.51% | 986.21M 3.04% | 1.047B 6.16% | 1.145B 9.36% | 1.219B 6.46% | 1.373B 12.63% | 1.415B 3.06% | 1.567B 10.74% | 1.663B 6.13% | |
| EBITDA YoY % growth | 217.822M -2.54% | 255.565M 17.33% | 266.334M 4.21% | 292.91M 9.98% | 328.12M 12.02% | 358.4M 9.23% | 419.48M 17.04% | 438.67M 4.57% | 604.82M 37.88% | N/A | |
| EBIT YoY % growth | 171.174M 1.83% | 190.587M 11.34% | 186.894M -1.94% | 211.15M 12.98% | 233.44M 10.56% | 265.29M 13.64% | 318.69M 20.13% | 339.82M 6.63% | 357.94M 5.33% | 379.8M 6.11% | |
| Operating Margin | 19.05% | 19.91% | 18.95% | 20.17% | 20.39% | 21.76% | 23.21% | 24.02% | 22.84% | 22.84% | |
| EPS YoY % growth | N/A | 0.99 4.50% | 0.97 -2.02% | 1.03 5.75% | 1.20 16.72% | 1.35 12.70% | 1.58 16.87% | 1.79 13.21% | N/A | N/A |
All data in EUR
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.22 17.57% | 0.26 0.63% | 0.29 -3.27% | 0.26 19.62% |
| Revenue Q2Q % growth | 236.95M 3.09% | 259.94M 3.02% | 277.95M 8.38% | 268.22M 8.34% |
| EBITDA Q2Q % growth | 64.557M 18.83% | 70.906M -18.79% | 76.673M -34.73% | 70.973M -41.23% |
| EBIT Q2Q % growth | 44.046M 23.06% | 49.474M -0.43% | 54.771M -8.90% | 49.543M 19.86% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 0.22 | 0.23 | -0.01 | -3.50% |
| Q3 2025 Q2Q % growth | 0.30 -3.23% | 0.30 | 0.00 | -1.05% |
| Q2 2025 Q2Q % growth | 0.26 52.94% | 0.25 | 0.01 | 5.48% |
| Q1 2025 Q2Q % growth | 0.19 -34.48% | 0.22 | -0.03 | -14.42% |
| Q4 2024 Q2Q % growth | 0.22 -4.35% | 0.25 | -0.03 | -10.99% |
| Q3 2024 Q2Q % growth | 0.31 | 0.21 | 0.10 | 50.83% |
| Q2 2024 Q2Q % growth | 0.17 | 0.21 | -0.04 | -20.63% |
| Q1 2024 Q2Q % growth | 0.29 | 0.28 | 0.01 | 3.11% |
| Q4 2023 Q2Q % growth | 0.23 | 0.16 | 0.07 | 40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 247.583M 4.44% | 252.62M | -5.037M | -1.99% |
| Q3 2025 Q2Q % growth | 256.46M 1.13% | 262.43M | -5.97M | -2.27% |
| Q2 2025 Q2Q % growth | 252.326M 7.95% | 247.99M | 4.336M | 1.75% |
| Q1 2025 Q2Q % growth | 229.841M -1.04% | 242.74M | -12.899M | -5.31% |
| Q4 2024 Q2Q % growth | 237.051M 3.73% | 244.39M | -7.339M | -3.00% |
| Q3 2024 Q2Q % growth | 253.587M -62.16% | 228.25M | 25.337M | 11.10% |
| Q2 2024 Q2Q % growth | 233.749M | 238.89M | -5.141M | -2.15% |
| Q1 2024 Q2Q % growth | 232.251M | 212M | 20.251M | 9.55% |
| Q4 2023 Q2Q % growth | 228.516M 12.57% | 233.12M | -4.604M | -1.97% |
| Q3 2023 Q2Q % growth | 670.086M 8.41% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.61% | -14.29% | -10.89% | -15.27% |
| Revenue | -3.21% | -5.48% | -4.21% | -5.42% |